The Department of Health and Human Services plans to amend its Public Readiness and Emergency Preparedness Act declaration for COVID-19 to extend liability protections for certain COVID-19 countermeasure activities beyond the May 11 end of the public health emergency, the agency announced today. Under the amendment, PREP Act liability immunity will apply through 2024 to all COVID-19 medical countermeasure activities provided through a federal agreement; and to pharmacists, pharmacy interns and pharmacy technicians who administer COVID-19 and seasonal flu vaccines and COVID-19 tests, regardless of a federal agreement or emergency declaration, HHS said. 

Related News Articles

Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
A new report from the National Academies of Sciences, Engineering, and Medicine calls for developing better diagnostics, vaccines and treatments to enhance U.S…
Headline
AHA March 18 shared with the House Ways and Means Committee its proposals to strengthen access to timely emergency medical care, particularly in rural and…
Headline
The AHA and other founding members of the Common Health Coalition March 13 committed to action in four priority areas: coordination between health care and…